<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

AU Small Finance Bank Limited

NSE: AUBANK · Lot size: 1000

AU Small Finance Bank Limited Open Interest & PCR Analysis

1,033.6Updated 21 Apr 2026, 01:26 pm IST
PCR
0.86
Neutral
Max Pain
970
Spot above by ₹64
Total CE OI
8.23M
Call writers
Total PE OI
7.10M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-04-21

Frequently Asked Questions

What is AU Small Finance Bank Limited PCR (Put-Call Ratio) today?
AU Small Finance Bank Limited's current PCR is 0.86. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. AU Small Finance Bank Limited's PCR of 0.86 indicates neutral sentiment.
What is AU Small Finance Bank Limited OI buildup type today?
AU Small Finance Bank Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for AU Small Finance Bank Limited?
AU Small Finance Bank Limited has total CE (call) OI of 8229000 contracts and total PE (put) OI of 7102000 contracts for the nearest expiry. The PCR is 0.86.
How is open interest analysis useful for AU Small Finance Bank Limited trading?
OI analysis for AU Small Finance Bank Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for AU Small Finance Bank Limited?
AU Small Finance Bank Limited's max pain is ₹970 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.